{
  "main_header": {
    "sid": 503586,
    "name": "Gayatri BioOrga.",
    "stock_name": "Gayatri BioOrga.",
    "full_name": "Gayatri BioOrganics Ltd",
    "name_url": "stocks-analysis/gayatri-bioorga",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6.94",
    "chg": -0.04,
    "chgp": "-0.57%",
    "dir": -1,
    "prev_price": "6.98",
    "mcapval": "54.68 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524564,
    "symbol": "",
    "ind_name": "Chemicals",
    "ind_code": 11,
    "isin": "INE052E01015",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "3.82 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gayatri-bioorga-503586-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gayatri BioOrganics Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gayatri-bioorganics-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-1110010",
        "imagepath": "",
        "date": "2025-02-25 10:30:28",
        "description": "Gayatri BioOrganics, a microcap player in the chemicals industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 6.01, slightly above its previous close of 5.92, with a 52-week range between 4.75 and 7.56. \n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while reflecting a mildly bullish stance monthly. The Relative Strength Index (RSI) presents a bullish signal on a monthly scale, although there is no signal on the weekly chart. Bollinger Bands and Dow Theory suggest bearish tendencies on the weekly front, while moving averages indicate a mildly bullish outlook daily.\n\nIn terms of returns, Gayatri BioOrganics has faced challenges compared to the Sensex. Over the past week, the stock has returned -4.60%, while the Sensex saw a decline of only -1.70%...."
      },
      {
        "title": "Gayatri BioOrganics Faces Financial Challenges Amidst Rising Promoter Confidence",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gayatri-bioorganics-receives-sell-rating-amid-flat-financial-performance-and-high-debt-1107365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/GayatriBioOrgan_mojoScore_509583.png",
        "date": "2025-02-24 18:12:01",
        "description": "Gayatri BioOrganics, a microcap in the chemicals sector, has recently experienced an evaluation adjustment amid flat financial performance for the quarter ending December 2024. The company faces challenges such as a negative book value and high debt-to-equity ratio, although there is increased promoter confidence suggesting potential for future improvement."
      }
    ],
    "total": 18,
    "sid": "503586",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/gayatri-bioorganics-503586"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Certificate under Reg-74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31-03-2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2025",
      "details": "Intimation for closure of trading window from 01-04-2025 till 48 hours after the declaration of audited financials of the company for the quarter and year ended on 31-03-2025",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "20-Feb-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahmed Raffe Pattan",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gayatri BioOrganics Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-02-25 10:30:28

Gayatri BioOrganics, a microcap player in the chemicals industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 6.01, slightly above its previous close of 5.92, with a 52-week range between 4.75 and 7.56. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while reflecting a mildly bullish stance monthly. The Relative Strength Index (RSI) presents a bullish signal on a monthly scale, although there is no signal on the weekly chart. Bollinger Bands and Dow Theory suggest bearish tendencies on the weekly front, while moving averages indicate a mildly bullish outlook daily. In terms of returns, Gayatri BioOrganics has faced challenges compared to the Sensex. Over the past week, the stock has returned -4.60%, while the Sensex saw a decline of only -1.70%....

Read More

Gayatri BioOrganics Faces Financial Challenges Amidst Rising Promoter Confidence

2025-02-24 18:12:01

Gayatri BioOrganics, a microcap in the chemicals sector, has recently experienced an evaluation adjustment amid flat financial performance for the quarter ending December 2024. The company faces challenges such as a negative book value and high debt-to-equity ratio, although there is increased promoter confidence suggesting potential for future improvement.

Read More

View All News